Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02548689 · ClinicalTrials.gov registry record
PAI-1 Expression in Non-scarring Hair Loss
A clinical trial, sponsored by Northwestern University.
- Terminated
- Registry status
- 10
- Enrollment target
NCT02548689 is a clinical trial that was terminated before completion, run by Northwestern University. The registered enrollment target is 10 participants.
The verdict
NCT02548689 was terminated before completion, sponsored by Northwestern University.
- TERMINATED
- Registry status
- 10 participants
- Enrollment target
Study Summary
This study will investigate whether subjects who suffer from hair loss have increased levels of PAI-1 compared to age-matched control subjects. The level of PAI-1 expression will be determined in subjects without hair loss and in subjects with non-scarring hair loss, including androgenetic alopecia, telogen effluvium and alopecia areata.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2015-07 |
| Est. Completion | 2021-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02548689
The ClinicalTrials.gov registry entry for NCT02548689 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02548689 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02548689 about?
NCT02548689 is a clinical study titled "PAI-1 Expression in Non-scarring Hair Loss". This study will investigate whether subjects who suffer from hair loss have increased levels of PAI-1 compared to age-matched control subjects. The level of PAI-1 expression will be determined in subjects without hair loss and in subjects with non-scarring hair loss, including androgenetic alopecia,...
What is the current status of trial NCT02548689?
This trial is currently terminated. The enrollment target is 10 participants. The study started on 2015-07. Estimated completion is 2021-06.
Who is sponsoring clinical trial NCT02548689?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.